Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients
Highlights ► Symptomatic treatment options for Alzheimer’s disease (AD) are currently limited to two therapeutic classes namely, acetylcholinesterase inhibitors (AChEIs) and memantine. ► The present review clarifies the effects of AChEIs and memantine on resting-state electroencephalographic (EEG) r...
Gespeichert in:
| Veröffentlicht in: | Clinical neurophysiology 2013-05, Vol.124 (5), p.837-850 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 850 |
|---|---|
| container_issue | 5 |
| container_start_page | 837 |
| container_title | Clinical neurophysiology |
| container_volume | 124 |
| creator | Babiloni, Claudio Del Percio, Claudio Bordet, Regis Bourriez, Jean-Luis Bentivoglio, Marina Payoux, Pierre Derambure, Philippe Dix, Sophie Infarinato, Francesco Lizio, Roberta Triggiani, Antonio Ivano Richardson, Jill C Rossini, Paolo M |
| description | Highlights ► Symptomatic treatment options for Alzheimer’s disease (AD) are currently limited to two therapeutic classes namely, acetylcholinesterase inhibitors (AChEIs) and memantine. ► The present review clarifies the effects of AChEIs and memantine on resting-state electroencephalographic (EEG) rhythms and cognitive function in AD patients to identify EEG markers useful for drug development. ► Based on the field literature, the patient’s EEG rhythms most reactive to AChEIs are those at delta (0–3 Hz), theta (4–7 Hz) and alpha (8–12 Hz); the effects of memantine generate a reduction of pathological theta rhythms. |
| doi_str_mv | 10.1016/j.clinph.2012.09.017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1327724501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1388245712006554</els_id><sourcerecordid>1327724501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-92c090c53c87a1af49cd7596cd15af9efff3d79c7544f02424e2913b92a5acf13</originalsourceid><addsrcrecordid>eNqFUstu1DAUjRCIlpY_QMhLNgm244zjDVJVlYdUiQV0bXmc68ZDYgdfT6VhxZ4v4Pf6JTiawqIbVr6Sz0P3nFtVrxhtGGWbt7vGTj4sY8Mp4w1VDWXySXXKesnrXnX8aZnbvq-56ORJ9QJxRymVVPDn1Qlvqeo3QpxWv66cA5uRREeMhXyY7BiLLmCGZBCID6Pf-hwTEhMGMsNsQi7_JAaSCsqH2xqzyUBgKkIpQrCwjGaKt8kso7ckjYc8zliUyMX0YwQ_Q7r_-RvJ4BFWi8VkDyHjefXMmQnh5cN7Vt28v_p6-bG-_vzh0-XFdW1F3-ZacUsVtV1re2mYcULZQXZqYwfWGafAOdcOUlnZCeEoF1wAV6zdKm46Yx1rz6o3R90lxe_7soOePVqYJhMg7lGzlktZYqMrVByhNkXEBE4vyc8mHTSjeq1B7_SxBr3WoKnSpYZCe_3gsN_OMPwj_c29AN4dAVD2vPOQNFq_Jjf4VFLUQ_T_c3gssIK8NdM3OADu4j6FkqFmGgtHf1lPYb0ExinddJ1o_wDq07UH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1327724501</pqid></control><display><type>article</type><title>Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Babiloni, Claudio ; Del Percio, Claudio ; Bordet, Regis ; Bourriez, Jean-Luis ; Bentivoglio, Marina ; Payoux, Pierre ; Derambure, Philippe ; Dix, Sophie ; Infarinato, Francesco ; Lizio, Roberta ; Triggiani, Antonio Ivano ; Richardson, Jill C ; Rossini, Paolo M</creator><creatorcontrib>Babiloni, Claudio ; Del Percio, Claudio ; Bordet, Regis ; Bourriez, Jean-Luis ; Bentivoglio, Marina ; Payoux, Pierre ; Derambure, Philippe ; Dix, Sophie ; Infarinato, Francesco ; Lizio, Roberta ; Triggiani, Antonio Ivano ; Richardson, Jill C ; Rossini, Paolo M</creatorcontrib><description>Highlights ► Symptomatic treatment options for Alzheimer’s disease (AD) are currently limited to two therapeutic classes namely, acetylcholinesterase inhibitors (AChEIs) and memantine. ► The present review clarifies the effects of AChEIs and memantine on resting-state electroencephalographic (EEG) rhythms and cognitive function in AD patients to identify EEG markers useful for drug development. ► Based on the field literature, the patient’s EEG rhythms most reactive to AChEIs are those at delta (0–3 Hz), theta (4–7 Hz) and alpha (8–12 Hz); the effects of memantine generate a reduction of pathological theta rhythms.</description><identifier>ISSN: 1388-2457</identifier><identifier>EISSN: 1872-8952</identifier><identifier>DOI: 10.1016/j.clinph.2012.09.017</identifier><identifier>PMID: 23098644</identifier><language>eng</language><publisher>Netherlands: Elsevier Ireland Ltd</publisher><subject>Alpha Rhythm - drug effects ; Alpha Rhythm - physiology ; Alzheimer Disease - drug therapy ; Alzheimer Disease - physiopathology ; Alzheimer’s disease ; Animals ; Cholinesterase Inhibitors - therapeutic use ; Cognition - drug effects ; Cognition - physiology ; Drug treatments ; Electroencephalography ; Electroencephalography (EEG) ; Humans ; Memantine - therapeutic use ; Neurology</subject><ispartof>Clinical neurophysiology, 2013-05, Vol.124 (5), p.837-850</ispartof><rights>International Federation of Clinical Neurophysiology</rights><rights>2012 International Federation of Clinical Neurophysiology</rights><rights>Copyright © 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-92c090c53c87a1af49cd7596cd15af9efff3d79c7544f02424e2913b92a5acf13</citedby><cites>FETCH-LOGICAL-c483t-92c090c53c87a1af49cd7596cd15af9efff3d79c7544f02424e2913b92a5acf13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1388245712006554$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23098644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Babiloni, Claudio</creatorcontrib><creatorcontrib>Del Percio, Claudio</creatorcontrib><creatorcontrib>Bordet, Regis</creatorcontrib><creatorcontrib>Bourriez, Jean-Luis</creatorcontrib><creatorcontrib>Bentivoglio, Marina</creatorcontrib><creatorcontrib>Payoux, Pierre</creatorcontrib><creatorcontrib>Derambure, Philippe</creatorcontrib><creatorcontrib>Dix, Sophie</creatorcontrib><creatorcontrib>Infarinato, Francesco</creatorcontrib><creatorcontrib>Lizio, Roberta</creatorcontrib><creatorcontrib>Triggiani, Antonio Ivano</creatorcontrib><creatorcontrib>Richardson, Jill C</creatorcontrib><creatorcontrib>Rossini, Paolo M</creatorcontrib><title>Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients</title><title>Clinical neurophysiology</title><addtitle>Clin Neurophysiol</addtitle><description>Highlights ► Symptomatic treatment options for Alzheimer’s disease (AD) are currently limited to two therapeutic classes namely, acetylcholinesterase inhibitors (AChEIs) and memantine. ► The present review clarifies the effects of AChEIs and memantine on resting-state electroencephalographic (EEG) rhythms and cognitive function in AD patients to identify EEG markers useful for drug development. ► Based on the field literature, the patient’s EEG rhythms most reactive to AChEIs are those at delta (0–3 Hz), theta (4–7 Hz) and alpha (8–12 Hz); the effects of memantine generate a reduction of pathological theta rhythms.</description><subject>Alpha Rhythm - drug effects</subject><subject>Alpha Rhythm - physiology</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer’s disease</subject><subject>Animals</subject><subject>Cholinesterase Inhibitors - therapeutic use</subject><subject>Cognition - drug effects</subject><subject>Cognition - physiology</subject><subject>Drug treatments</subject><subject>Electroencephalography</subject><subject>Electroencephalography (EEG)</subject><subject>Humans</subject><subject>Memantine - therapeutic use</subject><subject>Neurology</subject><issn>1388-2457</issn><issn>1872-8952</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUstu1DAUjRCIlpY_QMhLNgm244zjDVJVlYdUiQV0bXmc68ZDYgdfT6VhxZ4v4Pf6JTiawqIbVr6Sz0P3nFtVrxhtGGWbt7vGTj4sY8Mp4w1VDWXySXXKesnrXnX8aZnbvq-56ORJ9QJxRymVVPDn1Qlvqeo3QpxWv66cA5uRREeMhXyY7BiLLmCGZBCID6Pf-hwTEhMGMsNsQi7_JAaSCsqH2xqzyUBgKkIpQrCwjGaKt8kso7ckjYc8zliUyMX0YwQ_Q7r_-RvJ4BFWi8VkDyHjefXMmQnh5cN7Vt28v_p6-bG-_vzh0-XFdW1F3-ZacUsVtV1re2mYcULZQXZqYwfWGafAOdcOUlnZCeEoF1wAV6zdKm46Yx1rz6o3R90lxe_7soOePVqYJhMg7lGzlktZYqMrVByhNkXEBE4vyc8mHTSjeq1B7_SxBr3WoKnSpYZCe_3gsN_OMPwj_c29AN4dAVD2vPOQNFq_Jjf4VFLUQ_T_c3gssIK8NdM3OADu4j6FkqFmGgtHf1lPYb0ExinddJ1o_wDq07UH</recordid><startdate>20130501</startdate><enddate>20130501</enddate><creator>Babiloni, Claudio</creator><creator>Del Percio, Claudio</creator><creator>Bordet, Regis</creator><creator>Bourriez, Jean-Luis</creator><creator>Bentivoglio, Marina</creator><creator>Payoux, Pierre</creator><creator>Derambure, Philippe</creator><creator>Dix, Sophie</creator><creator>Infarinato, Francesco</creator><creator>Lizio, Roberta</creator><creator>Triggiani, Antonio Ivano</creator><creator>Richardson, Jill C</creator><creator>Rossini, Paolo M</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130501</creationdate><title>Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients</title><author>Babiloni, Claudio ; Del Percio, Claudio ; Bordet, Regis ; Bourriez, Jean-Luis ; Bentivoglio, Marina ; Payoux, Pierre ; Derambure, Philippe ; Dix, Sophie ; Infarinato, Francesco ; Lizio, Roberta ; Triggiani, Antonio Ivano ; Richardson, Jill C ; Rossini, Paolo M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-92c090c53c87a1af49cd7596cd15af9efff3d79c7544f02424e2913b92a5acf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Alpha Rhythm - drug effects</topic><topic>Alpha Rhythm - physiology</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer’s disease</topic><topic>Animals</topic><topic>Cholinesterase Inhibitors - therapeutic use</topic><topic>Cognition - drug effects</topic><topic>Cognition - physiology</topic><topic>Drug treatments</topic><topic>Electroencephalography</topic><topic>Electroencephalography (EEG)</topic><topic>Humans</topic><topic>Memantine - therapeutic use</topic><topic>Neurology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Babiloni, Claudio</creatorcontrib><creatorcontrib>Del Percio, Claudio</creatorcontrib><creatorcontrib>Bordet, Regis</creatorcontrib><creatorcontrib>Bourriez, Jean-Luis</creatorcontrib><creatorcontrib>Bentivoglio, Marina</creatorcontrib><creatorcontrib>Payoux, Pierre</creatorcontrib><creatorcontrib>Derambure, Philippe</creatorcontrib><creatorcontrib>Dix, Sophie</creatorcontrib><creatorcontrib>Infarinato, Francesco</creatorcontrib><creatorcontrib>Lizio, Roberta</creatorcontrib><creatorcontrib>Triggiani, Antonio Ivano</creatorcontrib><creatorcontrib>Richardson, Jill C</creatorcontrib><creatorcontrib>Rossini, Paolo M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neurophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Babiloni, Claudio</au><au>Del Percio, Claudio</au><au>Bordet, Regis</au><au>Bourriez, Jean-Luis</au><au>Bentivoglio, Marina</au><au>Payoux, Pierre</au><au>Derambure, Philippe</au><au>Dix, Sophie</au><au>Infarinato, Francesco</au><au>Lizio, Roberta</au><au>Triggiani, Antonio Ivano</au><au>Richardson, Jill C</au><au>Rossini, Paolo M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients</atitle><jtitle>Clinical neurophysiology</jtitle><addtitle>Clin Neurophysiol</addtitle><date>2013-05-01</date><risdate>2013</risdate><volume>124</volume><issue>5</issue><spage>837</spage><epage>850</epage><pages>837-850</pages><issn>1388-2457</issn><eissn>1872-8952</eissn><abstract>Highlights ► Symptomatic treatment options for Alzheimer’s disease (AD) are currently limited to two therapeutic classes namely, acetylcholinesterase inhibitors (AChEIs) and memantine. ► The present review clarifies the effects of AChEIs and memantine on resting-state electroencephalographic (EEG) rhythms and cognitive function in AD patients to identify EEG markers useful for drug development. ► Based on the field literature, the patient’s EEG rhythms most reactive to AChEIs are those at delta (0–3 Hz), theta (4–7 Hz) and alpha (8–12 Hz); the effects of memantine generate a reduction of pathological theta rhythms.</abstract><cop>Netherlands</cop><pub>Elsevier Ireland Ltd</pub><pmid>23098644</pmid><doi>10.1016/j.clinph.2012.09.017</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1388-2457 |
| ispartof | Clinical neurophysiology, 2013-05, Vol.124 (5), p.837-850 |
| issn | 1388-2457 1872-8952 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1327724501 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Alpha Rhythm - drug effects Alpha Rhythm - physiology Alzheimer Disease - drug therapy Alzheimer Disease - physiopathology Alzheimer’s disease Animals Cholinesterase Inhibitors - therapeutic use Cognition - drug effects Cognition - physiology Drug treatments Electroencephalography Electroencephalography (EEG) Humans Memantine - therapeutic use Neurology |
| title | Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T17%3A34%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20acetylcholinesterase%20inhibitors%20and%20memantine%20on%20resting-state%20electroencephalographic%20rhythms%20in%20Alzheimer%E2%80%99s%20disease%20patients&rft.jtitle=Clinical%20neurophysiology&rft.au=Babiloni,%20Claudio&rft.date=2013-05-01&rft.volume=124&rft.issue=5&rft.spage=837&rft.epage=850&rft.pages=837-850&rft.issn=1388-2457&rft.eissn=1872-8952&rft_id=info:doi/10.1016/j.clinph.2012.09.017&rft_dat=%3Cproquest_cross%3E1327724501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1327724501&rft_id=info:pmid/23098644&rft_els_id=S1388245712006554&rfr_iscdi=true |